SHANGHAI (Reuters) - China had more than 18,500 drugs waiting for approval at the end of 2014, up by a third from a year before, the official Center for Drug Evaluation said on Friday, reflecting industry concern that it is getting harder to get medicines approved in the China market.
Drug company executives say China has toughened the approval process, with companies forced to go through six to eight-year wait times in the world's second biggest pharmaceutical market, where spending is set to hit as much as $185 billion by 2018, according to IMS Health.
16:36 AT&T, Time Warner poised to lobby lawmakers, regulators on proposed $85-billion merger24
12:23 Lockheed Martin's quarterly profit handily beats estimates27
11:41 Caterpillar earnings: 85 cents per share, vs expected EPS of 76 cents22
16:51 Scottrade Sale Nearly Doubles Owner’s Wealth to $4 Billion16